Xu Z, Su P, Zhou X, Zheng Z, Zhu Y, Wang Q
Front Med (Lausanne). 2024; 11:1422306.
PMID: 39493720
PMC: 11527633.
DOI: 10.3389/fmed.2024.1422306.
Li Y, Wang Y, Liu Q, Lv S, Wang Y, Zhang H
J Orthop Surg Res. 2024; 19(1):678.
PMID: 39434162
PMC: 11495062.
DOI: 10.1186/s13018-024-05174-0.
Chen X, Liu J, Wang G, Sun Y, Ding X, Zhang X
Int J Gen Med. 2024; 17:3293-3318.
PMID: 39081673
PMC: 11288358.
DOI: 10.2147/IJGM.S466148.
Liu L, Zhang B, Zhou Z, Yang J, Li A, Wu Y
Drug Des Devel Ther. 2024; 18:1583-1602.
PMID: 38765877
PMC: 11102756.
DOI: 10.2147/DDDT.S455006.
Zhang Y, Liu H, Niu M, Wang Y, Xu R, Guo Y
Cell Death Discov. 2024; 10(1):235.
PMID: 38750059
PMC: 11096177.
DOI: 10.1038/s41420-024-02002-6.
LncRNA-mediated cartilage homeostasis in osteoarthritis: a narrative review.
Zhang L, Zhang H, Xie Q, Feng H, Li H, Li Z
Front Med (Lausanne). 2024; 11:1326843.
PMID: 38449881
PMC: 10915071.
DOI: 10.3389/fmed.2024.1326843.
Research advances of polyphenols in inflammatory diseases.
Qi J, Pan Z, Wang X, Zhang N, He G, Jiang X
Front Immunol. 2024; 15:1305886.
PMID: 38343532
PMC: 10853423.
DOI: 10.3389/fimmu.2024.1305886.
The emerging role of lncRNAs in osteoarthritis development and potential therapy.
Zhang X, Liu Q, Zhang J, Song C, Han Z, Wang J
Front Genet. 2023; 14:1273933.
PMID: 37779916
PMC: 10538550.
DOI: 10.3389/fgene.2023.1273933.
IRF-1-inhibited lncRNA XIST regulated the osteogenic differentiation via miR-450b/FBXW7 axis.
Song C, Guo Y, Chen F, Liu W
Apoptosis. 2023; 28(3-4):669-680.
PMID: 36800052
DOI: 10.1007/s10495-023-01820-w.
Molecular mechanisms of the Guizhi decoction on osteoarthritis based on an integrated network pharmacology and RNA sequencing approach with experimental validation.
Chen Y, Xue Y, Wang X, Jiang D, Xu Q, Wang L
Front Genet. 2023; 14:1079631.
PMID: 36760992
PMC: 9905689.
DOI: 10.3389/fgene.2023.1079631.
Natural Compounds: Potential Therapeutics for the Inhibition of Cartilage Matrix Degradation in Osteoarthritis.
Ashruf O, Ansari M
Life (Basel). 2023; 13(1).
PMID: 36676051
PMC: 9866583.
DOI: 10.3390/life13010102.
Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products.
Chuang Y, Tang J, Shiau J, Yen C, Chang F, Yang K
Cancers (Basel). 2023; 15(1).
PMID: 36612314
PMC: 9818271.
DOI: 10.3390/cancers15010318.
Overview of Anti-Inflammatory and Anti-Nociceptive Effects of Polyphenols to Halt Osteoarthritis: From Preclinical Studies to New Clinical Insights.
Gambari L, Cellamare A, Grassi F, Grigolo B, Panciera A, Ruffilli A
Int J Mol Sci. 2022; 23(24).
PMID: 36555503
PMC: 9779856.
DOI: 10.3390/ijms232415861.
A Study on the Potential Mechanism of Shujin Dingtong Recipe against Osteoarthritis Based on Network Pharmacology and Molecular Docking.
Yuan Z, Yang Z, Wu S
Comput Math Methods Med. 2022; 2022:1873004.
PMID: 36471753
PMC: 9719423.
DOI: 10.1155/2022/1873004.
Emerging role of lncRNAs in osteoarthritis: An updated review.
Wang R, Shiu H, Lee W
Front Immunol. 2022; 13:982773.
PMID: 36304464
PMC: 9593085.
DOI: 10.3389/fimmu.2022.982773.
Network pharmacology and molecular docking study on the effect of Kaempferol in treatment of metabolic associated fatty liver disease.
Kaixuan Z, Dong Z, Huiwei B, Lijing L
J Tradit Chin Med. 2022; 42(5):788-794.
PMID: 36083487
PMC: 9924677.
DOI: 10.19852/j.cnki.jtcm.20220815.003.
Elucidation of the Underlying Mechanism of Gujian Oral Liquid Acting on Osteoarthritis through Network Pharmacology, Molecular Docking, and Experiment.
Wu C, Ge Q, Shi Z, Ying J, Sun Q, Zhang S
Biomed Res Int. 2022; 2022:9230784.
PMID: 35937393
PMC: 9352474.
DOI: 10.1155/2022/9230784.
The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.
Siniscalchi C, Di Palo A, Russo A, Potenza N
Int J Mol Sci. 2022; 23(2).
PMID: 35054794
PMC: 8775829.
DOI: 10.3390/ijms23020611.